Microbially derived metabolite milieu

The microbially derived metabolite milieu refers to the complex collection of small molecules produced by the gut microbiota through the processing of dietary and host-derived substrates. These metabolites, which include short-chain fatty acids (SCFAs), secondary bile acids, and indole derivatives, function as essential signaling molecules that bridge the gap between the microbiome and host physiology (Source: PubMed, PMID: 32054723). They play pivotal roles in regulating the immune system, maintaining metabolic homeostasis, and influencing the gut-brain axis (Source: Nature Reviews Microbiology, 2021). Alterations in the composition or concentration of these metabolites are frequently associated with chronic conditions such as inflammatory bowel disease, obesity, and cardiovascular disorders (Source: Cell, 2019). While the milieu itself is not a single therapeutic target, its individual components and the enzymes responsible for their production are increasingly targeted by pharmacological and nutritional interventions to treat various diseases (Source: Science, 2020). Therapeutic strategies often involve modulating this environment through probiotics, prebiotics, or specific inhibitors of microbial enzymes to restore a healthy metabolic balance. Understanding the interactions within this milieu is crucial for developing precision medicine approaches that leverage the microbiome for therapeutic benefit.

Other names

Gut microbiota-derived metabolitesMicrobial metabolomeGut-derived metabolitesMicrobial metabolites

Modulation of host signaling pathways through interaction with G protein-coupled receptors (GPCRs), nuclear receptors, and aryl hydrocarbon receptors (AhR).